What Magodent does

Magodent, operating commercially under the LUX MED Onkologia brand, is a for-profit oncology hospital network headquartered in Warsaw, Poland. The company operates four hospital facilities in Warsaw (Szamocka, Św. Wincentego, Fieldorfa, and Św. Elżbiety), a specialized endotherapy center in Łódź, a rehabilitation center in Warsaw, and a wellness facility (Paxon Spa & Fitness). It delivers comprehensive cancer care spanning preventive screening (mammography, cytology, colonoscopy), diagnostic imaging and image-guided biopsies, robotic surgery for colorectal, prostate, and endometrial cancers using the da Vinci system, clinical oncology services (chemotherapy, hormonotherapy, immunotherapy, targeted therapies, drug programs), hematological and gynecological oncology, interventional radiology, and supportive care including rehabilitation, psychological support, and dietitian services. Designated as a Breast Cancer Unit and a Colorectal Cancer Unit, Magodent also runs free clinical trials outside NFZ coverage.

The company is part of the LUX MED Group and operates as a specialized oncology network embedded within Poland's public healthcare system. Its revenue model is anchored on contracts with NFZ (Narodowy Fundusz Zdrowia) — Poland's National Health Fund — under which insured citizens receive cancer screening, diagnostics, surgery, chemotherapy, hospitalization, and rehabilitation free at point of use; a smaller commercial/private revenue stream covers specialist consultations and select services outside NFZ coverage. Distribution relies on GP and specialist referrals via the DiLO (Oncological Patient Treatment Card) fast-track pathway, with direct patient-contact channels and dedicated treatment coordinators (e.g., for robotic prostate surgery). The network holds a five-year NFZ hospital-services authorization, accredited status from the Minister of Health, and has secured EU co-financing via European Funds for the Mazovia Region and funding through the National Recovery Plan (KPO), with partnerships including the National Oncology Institute (Narodowy Instytut Onkologii) and the Onkocafe patient support foundation.

Name

Magodent

Website

https://magodent.pl

Company type

Private

Founded year

1996

Operating status

Operating

Short description

Magodent (LUX MED Onkologia) is a private Polish oncology hospital network operating four Warsaw hospitals plus a Łódź endotherapy center and a rehabilitation center, delivering robotic and conventional cancer care, chemotherapy, and supportive services primarily under NFZ contracts.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111), Medical and Diagnostic Laboratories (6215)

SIC

Services-Health Services (8000), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Surgical Oncology (HLAKAFAG), Urologic Oncology (HLAKAOAB), Gynecologic Oncology (HLAKAFAF), Breast Oncology (HLAKAFAJ)

Keywords

• Oncology hospital services
• Cancer treatment centers
• Robotic cancer surgery
• Chemotherapy infusion services
• Preventive cancer screening

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. NFZ (National Health Fund) Contracts: The primary revenue stream is from contracts with Poland's National Health Fund (Narodowy Fundusz Zdrowia) covering all cancer diagnostic and treatment services including surgery, chemotherapy, hospitalization, rehabilitation, and preventive care. Services are free at point of use for insured patients.
2. Commercial/Private Services: Additional revenue from private pay medical services outside NFZ coverage, including specialist consultations, rehabilitation, and certain diagnostic procedures offered at commercial rates.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Magodent operates oncology hospitals and outpatient facilities providing cancer diagnostics, surgical treatment (including robotic surgery using the da Vinci system), chemotherapy, immunotherapy, targeted therapy, radiotherapy, rehabilitation, and preventive cancer screening. Services are delivered primarily through contracts with Poland's National Health Fund (NFZ) for insured patients, with additional commercial/private services offered for non-NFZ-covered care.

Product overview

LUX MED Onkologia is a network of oncology hospitals and specialized treatment centers in Poland offering comprehensive cancer care services. The portfolio includes four hospital facilities in Warsaw (Szamocka, Św. Wincentego, Fieldorfa, and św. Elżbiety), specialized centers for endotherapy in Łódź and rehabilitation in Warsaw, and spa facilities. Services span preventive screenings (breast, cervical, colorectal cancer), advanced diagnostics (laboratory, imaging, biopsies), robotic surgical procedures for colorectal, prostate, and endometrial cancers, clinical oncology treatments (chemotherapy, immunotherapy, targeted therapies), drug programs, clinical trials, and supportive care including rehabilitation, psychological support, and nutrition counseling. The organization operates under NFZ (National Health Fund) contracts providing free healthcare to Polish citizens, with additional commercial services available.

Differentiator

Problem solved

Functional benefit

Products and services

• Szpital Szamocka (LUX MED Onkologia Hospital) Oncology hospital in Warsaw offering surgical and inpatient oncology treatment services under NFZ coverage.
• Szpital Św. Wincentego (LUX MED Onkologia Hospital) Oncology hospital in Warsaw specializing in robotic cancer surgery including colorectal and endometrial cancer procedures.
• Szpital Fieldorfa (LUX MED Onkologia Hospital) Oncology hospital in Warsaw providing inpatient and outpatient oncology services including general surgical treatments.
• Szpital Św. Elżbiety (LUX MED Onkologia Hospital) Oncology hospital in Warsaw offering gynecological oncology and general surgical treatments for cancer patients.
• Endoterapia (Specialized Endotherapy Center) Specialized center in Łódź providing interventional endoscopic and endotherapy treatments.
• Centrum Rehabilitacji (Rehabilitation Center) Rehabilitation center in Warsaw offering pool-based physiotherapy and post-treatment rehabilitation services covered by NFZ.
• Robotic Surgery for Colorectal Cancer Robotic surgery for colorectal cancer using the da Vinci surgical system, performed under NFZ coverage at Szpital Św. Wincentego.
• Robotic Surgery for Prostate Cancer Robotic surgery for prostate cancer using the da Vinci system, performed under NFZ coverage with dedicated patient coordinator support.
• Robotic Surgery for Endometrial Cancer Robotic surgery for endometrial (uterine body) cancer using the da Vinci system under NFZ coverage.
• Clinical Oncology / Chemotherapy Hospital-based clinical oncology services including chemotherapy, hormonotherapy, immunotherapy, targeted therapies, and drug programs covered under NFZ.
• Fast Oncological Therapy (Szybka Terapia Onkologiczna) Fast-track diagnosis and treatment pathway for patients holding a DiLO (Oncological Patient Treatment Card), enabling rapid initiation of NFZ-covered oncology care.
• Breast Cancer Prevention (Mammography Screening) Free mammography screening program for breast cancer prevention under NFZ coverage.
• Cervical Cancer Prevention (Cytology Screening) Free cytology screening for cervical cancer prevention under NFZ coverage.
• Colorectal Cancer Prevention (Colonoscopy Screening) Free colonoscopy screening for colorectal cancer prevention under NFZ coverage.
• Breast Cancer Unit (Centrum Kompetencji Raka Piersi) Designated center of excellence providing comprehensive, coordinated breast cancer diagnosis, surgical treatment, chemotherapy, and reconstruction services.
• Colorectal Cancer Unit (Centrum Kompetencji Raka Jelita Grubego) Designated center of excellence providing comprehensive, coordinated colorectal cancer diagnosis and treatment, one of few hospitals in Poland with this certification.
• Hemato-oncology (Blood Cancer Treatment) Specialized hematology-oncology services for blood-related cancers including diagnosis and treatment under NFZ coverage.
• Gynecological Oncology Gynecological oncology services including diagnosis and treatment of uterine, cervical, and ovarian cancers under NFZ coverage.
• Cancer Diagnostics (Laboratory and Imaging) Comprehensive diagnostic services including laboratory tumor markers, ultrasound and CT imaging, CT/US-guided biopsies, and endoscopic diagnostic procedures under NFZ coverage.
• Clinical Trials (Badania Kliniczne) Free clinical trial participation for eligible oncology patients, providing access to investigational therapies outside of standard NFZ-covered treatment.
• Psychological Support for Cancer Patients Free psychological counseling and support services provided to cancer patients and their families outside of NFZ reimbursement.
• Dietitian Services Free dietitian consultations provided to cancer patients as part of supportive care outside NFZ reimbursement.
• Drug Programs (Programy Lekowe) NFZ-covered pharmaceutical treatment programs providing access to specialized oncology drugs for various cancer types.
• Oncology Rehabilitation Services Post-treatment physiotherapy and rehabilitation services for oncology patients, including pool-based physiotherapy covered by NFZ.
• Commercial/Private Medical Services Out-of-NFZ private specialist consultations, commercial rehabilitation services, and diagnostic procedures offered at published commercial rates.

Named customers6 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core and supportive.

• Narodowy Instytut Onkologii (National Oncology Institute)coreStrategic or Co-development PartnerPartnership with Poland's leading oncology research and treatment institution for clinical collaboration, knowledge sharing, and advanced cancer care protocols. The National Oncology Institute provides expertise and research support to enhance treatment outcomes.
• Fundacja OnkocafesupportiveGTM or Marketing PartnerCollaboration with cancer patient support foundation to provide additional resources, support services, and community outreach for cancer patients and their families.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie: Poland's National Oncology Institute is the leading state-run cancer center with which Magodent holds a strategic partnership. It is the benchmark reference for high-acuity oncology, clinical research, and protocol leadership, operating under the same NFZ reimbursement but as a public research institution in Warsaw and Gliwice/Branach.

Broad incumbents

• IHH Healthcare: IHH Healthcare operates a global network of tertiary hospitals including oncology specialty centers (e.g., Mount Elizabeth, Acibadem). It is the international large-cap reference for a specialty hospital roll-up and offers a template for capital structures and cross-border expansion relevant to Magodent's growth trajectory.
• LUX MED Group: LUX MED Group is the parent/affiliated corporate owner of LUX MED Onkologia/Magodent and Poland's largest private healthcare operator with broad hospital, outpatient, and diagnostic services. It is the broad incumbent reference point for scale, NFZ contracting leverage, and capital allocation within the same oncology franchise.
• Fresenius Helios: Fresenius Helios is Europe's largest private hospital operator with a deep specialty hospital portfolio. It is a useful broad-incumbent reference for specialized oncology hospital network economics, capital deployment, and multi-jurisdiction regulatory management relevant to scaling Magodent beyond Poland.

Direct peers

• Medicover Poland: Medicover operates a large Polish private hospital and diagnostic network combining NFZ and corporate-paid services. It overlaps with Magodent on oncology outpatient care, diagnostics, and employer-sponsored health plans, making it a directly comparable hybrid payer/provider.
• Enel-Med: Enel-Med is a Polish private healthcare chain combining hospital and outpatient oncology with NFZ and commercial revenue streams. It competes directly with Magodent for insured Polish oncology patients and physician talent in Warsaw and other major cities.
• Centrum Medyczne Damiana: Damian is a Polish private multi-specialty provider with hospital and outpatient oncology services under NFZ and commercial coverage. It competes for the same insured patient base in Warsaw and shares Magodent's hybrid public-reimbursement, private-pay model.
• Scanmed S.A. Scanmed is a Polish multi-specialty private hospital and outpatient network operating under NFZ contracts, with comparable inpatient and ambulatory oncology services. It is the closest domestic competitor profile to Magodent's mix of NFZ-funded hospital care plus specialty centers in Poland.
• Swissmed Centrum Zdrowia: Swissmed is a Polish specialty hospital and outpatient network offering NFZ-covered surgical and diagnostic services comparable to Magodent's offering. Its mixed public/private reimbursement model and specialty focus make it a directly comparable private operator in the same payer environment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Magodent